Thioacrylamide derivatives (Algiax Pharmaceuticals/JDRF)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameThioacrylamide derivatives (Algiax Pharmaceuticals/JDRF)
Drug Alias NameGABA A receptor modulator (Algiax Pharmaceuticals/JDRF)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsPainDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlgiax Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesBreakthrough T1DAlgiax Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPainDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A